V.A.C.
THErApy SAfETy INformATIoN
®
Disposable components of the V.A.C.
product labeling. V.A.C.
latex-free. All disposable components of the V.A.C.
help ensure safe and effective use, the V.A.C.
Dressing and V.A.C.
®
All disposable components of the V.A.C.
disposable components may result in wound contamination, infection and / or failure of the
wound to heal.
The decision to use clean versus sterile / aseptic technique is dependent upon wound
pathophysiology, physician / clinician preference and institutional protocol.
ImporTANT: As with any prescription medical device, failure to consult a physician and carefully
read and follow all therapy unit and dressing instructions and safety information prior to each use
may lead to improper product performance and the potential for serious or fatal injury. Do not
adjust therapy unit settings or perform therapy application without directions from / or supervision
by the treating physician.
Refer to the V.A.C.
®
Therapy Clinical Guidelines available at www.kci1.com or contact your local
KCI Representative for a printed copy.
INdICATIoNS for uSE
The ActiV.A.C.
, InfoV.A.C.
®
wound management systems for use in acute, extended and home care settings. They are
intended to create an environment that promotes wound healing by secondary or tertiary
(delayed primary) intention by preparing the wound bed for closure, reducing edema, promoting
granulation tissue formation and perfusion and by removing exudate and infectious material. They
are indicated for patients with chronic, acute, traumatic, subacute and dehisced wounds, partial-
thickness burns, ulcers (such as diabetic, pressure or venous insufficiency), flaps and grafts.
The V.A.C. GranuFoam Silver
help reduce infection in the above wound types.
CoNTrAINdICATIoNS
•
do not place foam dressings of the V.A.C.
exposed blood vessels, anastomotic sites, organs or nerves.
NoTE: Refer to Warnings section for additional information concerning Bleeding.
•
V.A.C.
Therapy is contraindicated for patients with:
®
•
Malignancy in the wound
•
Untreated osteomyelitis
NoTE: Refer to Warnings section for Osteomyelitis information.
•
Non-enteric and unexplored fistulas
•
Necrotic tissue with eschar present
NoTE: After debridement of necrotic tissue and complete removal of eschar, V.A.C.
Therapy may be used.
•
Sensitivity to silver (V.A.C. GranuFoam Silver
Therapy System are provided as indicated on the associated
®
Therapy Unit canisters are packaged sterile or fluid path sterile and are
®
WhiteFoam Dressings are to be used only with V.A.C.
Therapy System are for single use only. Re-use of
®
, V.A.C. ATS
and V.A.C. Freedom
®
®
Dressing is an effective barrier to bacterial penetration and may
®
Therapy System are for single use only. To
®
GranuFoam™ Dressing, V.A.C. GranuFoam Silver
®
Therapy Systems are integrated
®
Therapy System directly in contact with
®
Dressing only)
®
3
®
Therapy Units.
®
®